IFG
AUPH icon

Independent Financial Group’s Aurinia Pharmaceuticals AUPH Stock Holding History

Independent Financial Group’s Portfolio AUPH Stock Details AUPH Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2021
Q2 		– Sell
-112,930
Closed -$1.47M – 704
2021
Q1 		$1.47M Hold
112,930
– – 0.19% 131
2020
Q4 		$1.56M Buy
+112,930
New +$1.64M 0.23% 107
2020
Q3 		– Sell
-112,930
Closed -$1.84M – 510
2020
Q2 		$1.84M Hold
112,930
– – 0.4% 51
2020
Q1 		$1.64M Buy
+112,930
New +$1.99M 0.48% 40

Other funds holding AUPH

Fidelity Investments
Fidelity Investments Boston, Massachusetts $1.9T AUM 41.92% 1-Year Est. Return
O
OrbiMed New York $5.05B AUM 125.28% 1-Year Est. Return
NMC
NEA Management Company Timonium, Maryland $1.76B AUM 223.33% 1-Year Est. Return
Morgan Stanley
Morgan Stanley New York $1.66T AUM 25.57% 1-Year Est. Return
Susquehanna International Group
Susquehanna International Group Bala Cynwyd, Pennsylvania $893B AUM 36.07% 1-Year Est. Return
PAMU
Pictet Asset Management (UK) London, United Kingdom $91.8B AUM 47.77% 1-Year Est. Return
KCM
Kingdon Capital Management New York $911M AUM 51.11% 1-Year Est. Return
BBA
Baker Bros. Advisors New York $17.4B AUM 131.5% 1-Year Est. Return
AG
Artal Group Luxembourg $1.01B AUM 29.84% 1-Year Est. Return
Wells Fargo
Wells Fargo San Francisco, California $530B AUM 22.01% 1-Year Est. Return

Independent Financial Group's AUPH Position: Q2 2021 in Review

Independent Financial Group sold out of Aurinia Pharmaceuticals (AUPH) in Q2 2021, closing a stake of 112,930 shares — an estimated $1.47M sold.

Independent Financial Group first reported a position in AUPH in Q1 2020 and held it in 4 quarters. The position peaked at $1.84M in Q2 2020. 167 funds tracked by Wall St. Rank hold AUPH as of Q2 2021.

  • Independent Financial Group reported no remaining Aurinia Pharmaceuticals position as of Q2 2021 after selling out during the quarter.
  • Independent Financial Group sold 112,930 Aurinia Pharmaceuticals shares in Q2 2021, an estimated $1.47M.
  • Independent Financial Group first reported a position in Aurinia Pharmaceuticals in Q1 2020 and held it in 4 quarters.
  • Independent Financial Group's Aurinia Pharmaceuticals position peaked at $1.84M in Q2 2020.
  • 167 funds tracked by Wall St. Rank held Aurinia Pharmaceuticals as of Q2 2021.

Based on Independent Financial Group's 13F filing for Q2 2021, filed 15 Jun 2026.